saRNA therapeutics (MiNA Therapeutics/Boehringer Ingelheim)

N/A

Report date: 2025/03/20 15:59:39
NME

Base Information

Drug NamesaRNA therapeutics (MiNA Therapeutics/Boehringer Ingelheim)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > small activating RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMina Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBoehringer Ingelheim International GmbhMina Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A